Konkurrenz
| Unternehmen | Börsenwert | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
837,18 Mrd. | 23,56 % | 6/6 | 34,75 % | 14,84 % | 34,68 % | DOWN |
|
Johnson & Johnson NYSE:JNJ |
585,39 Mrd. | 5,27 % | 5/5 | 6,91 % | -33,06 % | 0,81 % | UP |
|
Merck NYSE:MRK |
298,84 Mrd. | 7,67 % | 6/6 | -21,36 % | -11,14 % | 9,21 % | UP |
|
Pfizer NYSE:PFE |
161,09 Mrd. | 7,82 % | 4/6 | -5,31 % | 18,13 % | -4,66 % | UP |
|
Bristol-Myers Squibb NYSE:BMY |
121,69 Mrd. | 1,77 % | 5/6 | -0,30 % | -2,46 % | 7,38 % | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
111,46 Mrd. | 13,44 % | 6/6 | 6,43 % | -1,68 % | 27,18 % | DOWN |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
78,18 Mrd. | 9,26 % | 5/6 | 5,41 % | 3,03 % | 14,85 % | UP |
|
Zoetis NYSE:ZTS |
49,79 Mrd. | 9,80 % | 6/6 | 7,18 % | 47,14 % | 22,94 % | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
24,75 Mrd. | 15,13 % | 5/6 | 2,41 % | -45,52 % | 14,46 % | UP |
|
Viatris NasdaqGS:VTRS |
15,48 Mrd. | -3,69 % | 4/6 | 2,85 % | -36,34 % | 26,49 % | UP |
|
Madrigal Pharmaceuticals NasdaqGS:MDGL |
12,55 Mrd. | 0,00 % | 2/4 | 0,00 % | 0,00 % | 17,39 % | UP |
|
Catalent NYSE:CTLT |
11,52 Mrd. | -5,82 % | 2/6 | 27,69 % | -22,42 % | 0,03 % | UP |
|
Cytokinetics NasdaqGS:CYTK |
8,22 Mrd. | -1,08 % | 1/6 | 4,92 % | -45,76 % | 37,87 % | UP |
|
Balchem NasdaqGS:BCPC |
5,46 Mrd. | 8,75 % | 6/6 | 8,46 % | 2,53 % | 18,82 % | UP |
|
TG Therapeutics NasdaqCM:TGTX |
4,95 Mrd. | 63,45 % | 3/5 | 33,54 % | 93,05 % | 37,19 % | UP |
|
Indivior Pharmaceuticals NasdaqGS:INDV |
3,74 Mrd. | 28,91 % | 5/6 | 13,62 % | 0,06 % | 18,30 % | UP |
|
Corcept Therapeutics NasdaqCM:CORT |
4,52 Mrd. | 10,36 % | 5/6 | 118,76 % | 14,90 % | 41,21 % | DOWN |
|
Ligand Pharmaceuticals NasdaqGM:LGND |
3,98 Mrd. | 7,83 % | 5/6 | 3,60 % | -47,49 % | 21,00 % | UP |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
2,91 Mrd. | 2,48 % | 3/6 | 8,61 % | -29,27 % | 28,76 % | UP |
|
Nektar Therapeutics NasdaqCM:NKTR |
2,21 Mrd. | 65,15 % | 4/6 | 74,02 % | -475,40 % | 70,80 % | UP |
























